On Tuesday, one stock made Jim Cramer cringe at the very thought of it: Lumber Liquidators. A caller asked about it in the Lightning Round, and Cramer responded by saying that this company was so bad he wouldn't even say its name. Yikes!
There are plenty of other businesses to talk about though. Last week, the market flooded with 13 initial public offerings, making it the busiest week for IPOs in 2015. And Cramer sees that this wasn't just one isolated incident, as the market has had a steady acceleration of IPOs this year.
Could they all be good for investing, or could some be toxic for your portfolio?
"Regular viewers know that I don't like it when we get deluged with so many new issues. The stock market is just like any other market: it's all about supply and demand. These IPOs all represent additional supply, and when the supply goes up while demand stays the same, you can expect prices to go down," the "Mad Money" host said.
That in mind, Cramer walked investors through the most important IPOs of last week.
Last Thursday a small-cap medical technology company called Glaukos came public at $18 a share and then skyrocketed to $31.22 on its first day of trading. The company is focused on creating products and procedures that change the way glaucoma is treated.
In particular, it has pioneered a procedure known as micro-invasive glaucoma surgery. Thus far, the company has had rapid revenue growth but is still far from profitable. And even with all of its snazzy technology, it's not clear to Cramer how Glaukos will ever turn a profit.
Finally, there is TransUnion, which went public last Thursday at $22.50 and jumped up to $25.40 on its first day of trading. While some may know TransUnion as a simple credit reporting agency, the company considers itself to be a sophisticated information provider.
However, the "Mad Money" host is not a fan of TransUnion. The company is unprofitable and was cash-flow negative in 2013 and 2014 with an ugly balance sheet in debt for $3 billion. Granted, the company plans to use most of the some $700 million it raised in the IPO to pay down the debt, but it still won't leave it in a great position.
"I am not impressed by last week's crop of IPOs…These are not high-quality companies, and it worries me that we're seeing so many of them come public at the same time," Cramer added.
So, while Cramer does not bring good news with most of the IPOs, it is his job to look out for investors and make sure these vicious IPOs don't wreak havoc on their portfolio.